IGFBP3 and type 1 diabetes mellitus: Evidence has suggested that patients with T1D may have aberrations of the GH/IGF/IGFBP axis, including GH hypersecretion, decreased concentrations of circulating IGF-1 and IGFBP-3, and elevated levels of IGFBP-1 [12].